The summaries are free for public use. ARTHROS will continue to add and archive summaries of articles deemed relevant to ARTHROS by our Faculty.
| 1 | |
At the Heart of Eosinophilic Granulomatosis with Polyangiitis: into Cardiac and Vascular Involvement |
Curr Rheumatol Rep. 2022 Nov;24(11):337-351. doi: 10.1007/s11926-022-01087-1.Epub 2022 Oct 4.
Milena Bond # 1, Filippo Fagni # 2, Michele Moretti 3, Federica Bello 4, Allyson Egan 5, Augusto Vaglio 6 7, Giacomo Emmi 4, Christian Dejaco 8 9 |
| 2 | |
How best to manage relapse and remission in ANCA-associated vasculitis |
Expert Rev Clin Immunol. 2022 Nov;18(11):1135-1143. doi: 10.1080/1744666X.2022.2122954.Epub 2022 Sep 14.
|
| 4 | |
High risk of stroke in ANCA-associated vasculitis-a population-based study |
Rheumatology (Oxford). 2022 Nov 28;keac669. doi: 10.1093/rheumatology/keac669.Online ahead of print.
Dennis Tabakovic 1, Rona Smith 2 3, David Jayne 2 3, Aladdin J Mohammad 1 3 |
| 5 | |
Immunoglobulin A Vasculitis Following COVID-19: A French Multicenter Case Series |
J Rheumatol. 2022 Dec;49(12):1390-1394. doi: 10.3899/jrheum.220503.Epub 2022 Sep 1. Yanis Ramdani 1, Jean Marc Galempoix 2, Jean François Augusto 3, Eva Dekmeer 4, Laurent Perard 5, Nicole Ferreira 6, Adrien Bigot 6, Julie Magnant 6, Stéphanie Jobard 6, Elisabeth Diot 6, Marie Charlotte Besse 6, Hélène Henrique 6, François Maillot 1, Alexandra Audemard-Verger 1 |
| 7 | |
At the Heart of Eosinophilic Granulomatosis with Polyangiitis: into Cardiac and Vascular Involvement |
Curr Rheumatol Rep. 2022 Nov;24(11):337-351. doi: 10.1007/s11926-022-01087-1.Epub 2022 Oct 4.
Milena Bond # 1, Filippo Fagni # 2, Michele Moretti 3, Federica Bello 4, Allyson Egan 5, Augusto Vaglio 6 7, Giacomo Emmi 4, Christian Dejaco 8 9 |
| 8 | |
Avacopan for the treatment of ANCA-associated vasculitis: an update |
Expert Rev Clin Immunol. 2022 Dec 26;1-11. doi: 10.1080/1744666X.2023.2162041.Online ahead of print.
Mohammed Osman 1, Jan Willem Cohen Tervaert 1, Christian Pagnoux 2 |
| 9 | |
How best to manage relapse and remission in ANCA-associated vasculitis |
Expert Rev Clin Immunol. 2022 Nov;18(11):1135-1143. doi: 10.1080/1744666X.2022.2122954.Epub 2022 Sep 14.
|
| 10 | |
Cutaneous manifestations of antineutrophil cytoplasmic antibody-associated vasculitis (AAV): a concise review with emphasis on clinical and histopathologic correlation |
Int J Dermatol. 2022 Dec;61(12):1442-1451. doi: 10.1111/ijd.16247.Epub 2022 May 22.
|
| 11 | |
Ocular manifestations of ANCA-associated vasculitis |
Rheumatology (Oxford). 2022 Nov 28;keac663. doi: 10.1093/rheumatology/keac663.Online ahead of print.
Mats L Junek 1, Lily Zhao 1, Stephanie Garner 1, David Cuthbertson 2, Christian Pagnoux 3, Curry L Koening 4, Carol A Langford 5, Carol A McAlear 6, Paul A Monach 7, Larry W Moreland 8, Rennie L Rhee 6, Philip Seo 9, Ulrich Specks 10, Antoine G Sreih 6, Kenneth Warrington 10, Michael E Wechsler 11, Peter A Merkel 6, Nader A Khalidi 1, Vasculitis Clinical Research Consortium |
| 12 | |
Giant cell arteritis: Update on clinical manifestations, diagnosis, and management |
Eur J Intern Med. 2022 Nov 4;S0953-6205(22)00386-7.doi: 10.1016/j.ejim.2022.10.025. Online ahead of print.
Nicola Farina 1, Alessandro Tomelleri 2, Corrado Campochiaro 1, Lorenzo Dagna 1 |
| 13 | |
Arterial stiffness, endothelial dysfunction and impaired fibrinolysis are pathogenic mechanisms contributing to cardiovascular risk in ANCA-associated vasculitis |
Kidney Int. 2022 Nov;102(5):1115-1126.doi: 10.1016/j.kint.2022.07.026. Epub 2022 Aug 20. Tariq E Farrah 1, Vanessa Melville 2, Alicja Czopek 3, Henry Fok 4, Lorraine Bruce 3, Nicholas L Mills 5, Matthew A Bailey 3, David J Webb 6, James W Dear 3, Neeraj Dhaun 7 |
| 14 | |
Evolution of ultrasound in giant cell arteritis |
Front Med (Lausanne). 2022 Oct 3;9:981659. doi: 10.3389/fmed.2022.981659.eCollection 2022.
Colm Kirby 1 2, Rachael Flood 1, Ronan Mullan 1, Grainne Murphy 2, David Kane 1 |
| 15 | |
A comprehensive guide for managing the reproductive health of patients with vasculitis |
Nat Rev Rheumatol. 2022 Oct 3;1-13. doi: 10.1038/s41584-022-00842-z.Online ahead of print.
|
| 16 | |
Induction and maintenance of remission with mycophenolate mofetil in ANCA-associated vasculitis: a systematic review and meta-analysis |
Nephrol Dial Transplant. 2022 Oct 19;37(11):2190-2200.doi: 10.1093/ndt/gfab357.
Alvise Berti 1, Mouaz Alsawas 2 3, Tabinda Jawaid 2, Larry J Prokop 4, Jiwon M Lee 5, Gwang Hun Jeong 6, Luis F Quintana 7, Sergey Moiseev 8, Augusto Vaglio 9, Vladimir Tesar 10, Duvuru Geetha 11, Jae I L Shin 12, Andreas Kronbichler 13 14 |
| 17 | |
Granulomatosis With Polyangiitis Presenting With Diffuse Alveolar Hemorrhage: A Systematic Review |
| 18 | |
Fatigue in ANCA-associated vasculitis (AAV) and systemic sclerosis (SSc): similarities with Myalgic encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). A critical review of the literature |
Expert Rev Clin Immunol. 2022 Oct;18(10):1049-1070.doi: 10.1080/1744666X.2022.2116002. Epub 2022 Aug 31.
Charmaine van Eeden 1, Mohammed S Osman 1, Jan Willem Cohen Tervaert 1 2 |
| 19 | |
Vision loss in giant cell arteritis: case-based review |
Rheumatol Int. 2022 Oct;42(10):1855-1862. doi: 10.1007/s00296-022-05160-x.Epub 2022 Jun 21.
Ioanna Nefeli Kokloni 1, Souzana Ioanna Aligianni 1, Olga Makri 2, Dimitrios Daoussis 3 |
| 20 | |
Environmental Triggers for Vasculitis |
| 21 | |
Complications of Vascular Disease |
Anesthesiol Clin. 2022 Dec;40(4):587-604. doi: 10.1016/j.anclin.2022.08.006.Epub 2022 Oct 1.
|
| 22 | |
Spectrum of Large- and Medium-Vessel Vasculitis in Adults: Neoplastic, Infectious, Drug-Induced, Autoinflammatory, and Primary Immunodeficiency Diseases |
Curr Rheumatol Rep. 2022 Oct;24(10):293-309. doi: 10.1007/s11926-022-01083-5.Epub 2022 Aug 3.
Fabian Lötscher # 1, Roxana Pop # 2, Pascal Seitz 1, Mike Recher 3 4, Luca Seitz 5 6 |
| 23 | |
Giant Cell Arteritis: A Case-Based Narrative Review of the Literature |
Curr Pain Headache Rep. 2022 Oct;26(10):725-740.doi: 10.1007/s11916-022-01075-1. Epub 2022 Sep 3.
Davis C Thomas 1, Prisly Thomas 2, Deep P Pillai 2, Dahlia Joseph 3, Upasana Lingaiah 4, Blessy C Mathai 5, Anjali Ravi 6, Surabhi Chhabra 7, Priyanka Kodaganallur Pitchumani 8 |
| 24 | |
Giant cell arteritis: what is new in the preclinical and early clinical development pipeline? |
Expert Opin Investig Drugs. 2022 Sep;31(9):921-932.doi: 10.1080/13543784.2021.1940949. Epub 2021 Jun 30.
|
| 25 | |
Concurrent baseline diagnosis of giant cell arteritis and polymyalgia rheumatica - A systematic review and meta-analysis |
Semin Arthritis Rheum. 2022 Oct;56:152069. doi: 10.1016/j.semarthrit.2022.152069.Epub 2022 Jul 13.
Andreas Wiggers Nielsen 1, Line Lier Frølund 2, Christoffer Våben 2, Asta Roos Bonde 2, Lars Christian Gormsen 3, Annette Ladefoged de Thurah 4, Ellen-Margrethe Hauge 4, Kresten Krarup Keller 4 |
| 26 | |
Evidence-based Role of Aspirin in Giant Cell Arteritis: A Literature Review |
J Community Hosp Intern Med Perspect. 2022 Sep 9;12(5):11-16.doi: 10.55729/2000-9666.1072. eCollection 2022.
Anum Qureshi 1, Fatima Halilu 1, Sam W Serafi 1 2, Howard Hauptman 1 2, Tristan Flack 1 |
| 27 | |
Consensus Treatment Plans for Severe Pediatric Antineutrophil Cytoplasmic Antibody-Associated Vasculitis |
Arthritis Care Res (Hoboken) 2022 Sep;74(9):1550-1558. doi: 10.1002/acr.24590.Epub 2022 Jun 1.
Kimberly A Morishita 1, Linda Wagner-Weiner 2, Eric Y Yen 3, Vidya Sivaraman 4, Karen E James 5, Dana Gerstbacher 6, Ann M Szymanski 7, Kathleen M O'Neil 8, David A Cabral 1, Childhood Arthritis and Rheumatology Research Alliance (CARRA) Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Workgroup |
| 28 | |
A Spotlight on Drug-Induced Vasculitis |
Curr Rheumatol Rep. 2022 Nov;24(11):323-336. doi: 10.1007/s11926-022-01088-0.Epub 2022 Sep 21.
|
| 29 | |
Serum ANCA as Disease Biomarkers: Clinical Implications Beyond Vasculitis |
Clin Rev Allergy Immunol. 2022 Oct;63(2):107-123.doi: 10.1007/s12016-021-08887-w. Epub 2021 Aug 30.
Marco Folci 1 2, Giacomo Ramponi 3, Virginia Solitano 4, Enrico Brunetta 5 4 |
| 30 | |
Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management |
Nat Rev Rheumatol. 2022 Oct;18(10):559-574. doi: 10.1038/s41584-022-00819-y.Epub 2022 Sep 15.
Giorgio Trivioli 1 2, Ana Marquez 3, Davide Martorana 4 5, Michelangelo Tesi 2, Andreas Kronbichler 6 7, Paul A Lyons 6 8, Augusto Vaglio 9 10 |
| 31 | |
Identification and functional characterization of a novel susceptibility locus for small vessel vasculitis with MPO-ANCA |
Rheumatology (Oxford). 2022 Aug 3;61(8):3461-3470. doi: 10.1093/rheumatology/keab912.
Johanna Dahlqvist 1 2 3, Diana Ekman 4, Bengt Sennblad 5, Sergey V Kozyrev 2, Jessika Nordin 2, Åsa Karlsson 2, Jennifer R S Meadows 2, Erik Hellbacher 1, Solbritt Rantapää-Dahlqvist 6, Ewa Berglin 6, Bernd Stegmayr 6, Bo Baslund 7, Øyvind Palm 8, Hilde Haukeland 9, Iva Gunnarsson 10 11, Annette Bruchfeld 12 13, Mårten Segelmark 14, Sophie Ohlsson 14, Aladdin J Mohammad 15 16, Anna Svärd 17, Rille Pullerits 18 19, Hans Herlitz 20, Annika Söderbergh 21, Gerli Rosengren Pielberg 2, Lina Hultin Rosenberg 2, Matteo Bianchi 2, Eva Murén 2, Roald Omdal 22 23, Roland Jonsson 24, Maija-Leena Eloranta 1, Lars Rönnblom 1, Peter Söderkvist 25, Ann Knight 1, Per Eriksson 26, Kerstin Lindblad-Toh 2 3 |
| 32 | |
Navigating the initial diagnosis and management of adult IgA vasculitis: A review |
JAAD Int. 2022 Jun 13;8:71-78. doi: 10.1016/j.jdin.2022.05.004. eCollection 2022 Sep.
Brenna G Kelly 1 2, Delaney B Stratton 1, Iyad Mansour 3, Bekir Tanriover 3, Keliegh S Culpepper 1 4, Clara Curiel-Lewandrowski 1 |
| 33 | |
Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remission |
Ann Rheum Dis. 2022 Aug 16;annrheumdis-2022-222479. doi: 10.1136/ard-2022-222479.Online ahead of print.
Gabriele Gamerith 1, Finn Mildner 1, Peter A Merkel 2, Kristina Harris 3, Laura Cooney 3, Noha Lim 3, Robert Spiera 4, Philip Seo 5, Carol A Langford 6, Gary S Hoffman 6, E William St Clair 7, Fernando C Fervenza 8, Paul Monach 9, Steven R Ytterberg 10, Duvuru Geetha 11, Arno Amann 1, Dominik Wolf 1, Ulrich Specks 12, John H Stone 13, Andreas Kronbichler 14 |
| 34 | |
Comparing treatment options for large vessel vasculitis |
Expert Rev Clin Immunol. 2022 Aug;18(8):793-805.doi: 10.1080/1744666X.2022.2092098. Epub 2022 Jun 29.
Federica Macaluso 1 2, Chiara Marvisi 1 3, Paola Castrignanò 1 3, Nicolò Pipitone 1, Carlo Salvarani 1 3 |
| 35 | |
New developments in treatments for systemic vasculitis |
Curr Opin Pharmacol. 2022 Jul 31;66:102270. doi: 10.1016/j.coph.2022.102270.Online ahead of print.
|
| 36 | |
Obinutuzumab as treatment for ANCA-associated vasculitis |
Rheumatology (Oxford). 2022 Aug 30;61(9):3814-3817.doi: 10.1093/rheumatology/keab916.
Naomi A Amudala 1, Sara Boukhlal 2, Brittany Sheridan 3, Carol A Langford 4, Abdallah Geara 3, Peter A Merkel 5, Divi Cornec 2 |
| 37 | |
Relationship Between Cerebrovascular Diseases and Vasculitis: A Cross-Sectional Nationwide Inpatient Study |
Cureus. 2022 Jul 29;14(7):e27435. doi: 10.7759/cureus.27435. eCollection 2022 Jul.
Anusheel 1, Johanna S Canenguez Benitez 2, Sanobar Jaka 3, Nikhita S Roshan 4, Sravani Kommuru 5, Samreen Ahmed 6, Gagan Kaur 7, Ninad Desai 8 |
| 38 | |
What to Know About Biopsy Sampling and Pathology in Vasculitis? |
Curr Rheumatol Rep. 2022 Sep;24(9):279-291. doi: 10.1007/s11926-022-01082-6.Epub 2022 Jul 27.
Chiara Marvisi # 1 2, Francesco Muratore # 3, Chiara Cabassi 1 2, Elena Galli 1 2, Luigi Boiardi 1, Simonetta Piana 4, Maria Cecilia Mengoli 4, Carlo Salvarani 1 2, Alberto Cavazza 4 |
| 39 | |
Added value of Joint ENT-Rheumatology clinic in the management of ANCA-associated vasculitis: One year's experience |
Am J Otolaryngol. 2022 Jul-Aug;43(4):103485. doi: 10.1016/j.amjoto.2022.103485.Epub 2022 May 5.
M Stavrakas 1, R Smith 2, M Akil 2, K-P Kuet 2, F Morley 3, J Ray 3 |
| 40 | |
Treatment Guidelines in Vasculitis |
Rheum Dis Clin North Am. 2022 Aug;48(3):705-724. doi: 10.1016/j.rdc.2022.03.006.Epub 2022 Jul 5.
|
| 42 | |
Pediatric cardiothoracic vasculitis: multimodality imaging review |
Pediatr Radiol. 2022 Jul 6;1-15. doi: 10.1007/s00247-022-05431-6.Online ahead of print.
|
| 43 | |
Practice patterns and outcomes for pediatric ANCA vasculitis transplant recipients in a national cohort |
Pediatr Nephrol. 2022 Jul;37(7):1667-1673. doi: 10.1007/s00467-021-05341-z.Epub 2021 Nov 18.
Stella Kilduff 1, Jonathan Butler 2, Hiroshi Sogawa 3, Sonia Solomon 4 |
| 44 | |
New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension |
Rheumatology (Oxford). 2022 Jul 6;61(7):2915-2922.doi: 10.1093/rheumatology/keab780.
John H Stone 1, Helen Spotswood 2, Sebastian H Unizony 1, Martin Aringer 3, Daniel Blockmans 4, Elisabeth Brouwer 5, Maria C Cid 6, Bhaskar Dasgupta 7, Juergen Rech 8, Carlo Salvarani 9, Robert Spiera 10, Min Bao 11 |
| 45 | |
Interstitial Lung Disease in ANCA-Associated Vasculitis: Pathogenic Considerations and Impact for Patients' Outcomes |
Curr Rheumatol Rep. 2022 Aug;24(8):259-267. doi: 10.1007/s11926-022-01078-2.Epub 2022 Jul 7.
|
| 46 | |
Journal Club Review of "Avacopan for the Treatment of ANCA-Associated Vasculitis" |
ACR Open Rheumatol. 2022 Jul;4(7):558-561. doi: 10.1002/acr2.11412. Epub 2022 Feb 15.
|
| 47 | |
ANCA associated vasculitis (AAV): a review for internists |
Postgrad Med. 2022 Jul 21;1-11. doi: 10.1080/00325481.2022.2102368.Online ahead of print.
|
| 48 | |
Vasculitis: What Have We Learned in the Last 50 Years? |
J Rheumatol. 2022 Jul;49(7):848-852. doi: 10.3899/jrheum.220207. Epub 2022 May 15.
|
| 49 | |
Polyarteritis nodosa: an evolving primary systemic vasculitis |
Postgrad Med. 2022 Jun 22;1-8. doi: 10.1080/00325481.2022.2088940.Online ahead of print.
|
| 50 | |
Cranial giant cell arteritis mimickers: A masquerade to unveil |
Autoimmun Rev. 2022 May;21(5):103083. doi: 10.1016/j.autrev.2022.103083.Epub 2022 Mar 24.
Gerasimos Evangelatos 1, Alexandros Grivas 2, Maria Pappa 3, Konstantina Kouna 4, Alexios Iliopoulos 4, George E Fragoulis 3 |
| 51 | |
Mechanisms of vascular damage in ANCA vasculitis |
Semin Immunopathol. 2022 May;44(3):325-345.doi: 10.1007/s00281-022-00920-0. Epub 2022 Mar 7.
David Massicotte-Azarniouch 1, Carolina A Herrera 1 2, J Charles Jennette 2, Ronald J Falk 1, Meghan E Free 3 |
| 52 | |
How the availability of anti-C5a agents could change the management of ANCA-associated Vasculitis |
Kidney Blood Press Res. 2022 Jun 3. doi: 10.1159/000525357. Online ahead of print. Dario Roccatello, Roberta Fenoglio, Valentina Oddone, Savino Sciascia |
| 53 | |
Therapeutic advances in eosinophilic granulomatosis with polyangiitis |
Curr Opin Rheumatol. 2022 May 1;34(3):158-164.doi: 10.1097/BOR.0000000000000873. Epub 2022 Apr 18.
|
| 54 | |
Tocilizumab for giant cell arteritis |
Cochrane Database Syst Rev. 2022 May 13;5(5):CD013484.doi: 10.1002/14651858.CD013484.pub3.
|
| 55 | |
Intravenous tocilizumab for the treatment of giant cell arteritis: a phase Ib dose-ranging pharmacokinetic bridging study |
Arthritis Res Ther. 2022 Jun 4;24(1):133. doi: 10.1186/s13075-022-02815-9.
Christophe Schmitt 1, Laura Brockwell 2, Mylène Giraudon 3, Mauro Zucchetto 4, Lisa Christ 5, Bettina Bannert 6, Thomas Daikeler # 6, Peter M Villiger # 7 |
| 56 | |
Arterial Stiffness and Adult Onset Vasculitis: A Systematic Review |
Front Med (Lausanne). 2022 May 12;9:824630. doi: 10.3389/fmed.2022.824630.eCollection 2022.
Alberto Lo Gullo 1, Clemente Giuffrida 2, Carmela Morace 3, Giovanni Squadrito 3, Paola Magnano San Lio 4, Luisa Ricciardi 5, Carlo Salvarani 6, Giuseppe Mandraffino 3 |
| 57 | |
Sjögren syndrome overlapping with ANCA-associated vasculitis: Four additional cases and systematic literature review |
Autoimmun Rev. 2022 Jun;21(6):103099. doi: 10.1016/j.autrev.2022.103099.Epub 2022 Apr 19.
Cyrille Coustal 1, Béatrice Guillope 2, Chris Serrand 3, Jacques Morel 4, Guillaume Taieb 5, Elodie Castille 1, Kaoutar Meliani 1, Olivier Darmon 1, Radjiv Goulabchand 6, Philippe Guilpain 7 |
| 58 | |
Systematic Review and Metaanalysis of Worldwide Incidence and Prevalence of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis |
J Clin Med. 2022 May 4;11(9):2573. doi: 10.3390/jcm11092573.
Rocío Redondo-Rodriguez 1, Natalia Mena-Vázquez 1, Alba María Cabezas-Lucena 1, Sara Manrique-Arija 1 2, Arkaitz Mucientes 1, Antonio Fernández-Nebro 1 2 |
| 59 | |
The role of neutrophils in rheumatic disease-associated vascular inflammation |
Nat Rev Rheumatol. 2022 Mar;18(3):158-170. doi: 10.1038/s41584-021-00738-4.Epub 2022 Jan 17.
|
| 60 | |
A systematic review of clinical and preclinical evidences for Janus kinase inhibitors in large vessel vasculitis |
Clin Rheumatol. 2022 Jan;41(1):33-44. doi: 10.1007/s10067-021-05973-4.Epub 2021 Nov 3.
Upendra Rathore 1, Darpan Radheshyam Thakare 1, Pallavi Patro 2, Vikas Agarwal 1, Aman Sharma 3, Durga Prasanna Misra 4 |
| 61 | |
Endovascular Therapy for Intracranial Giant Cell Arteritis : Systematic Review, Technical Considerations and the Effect of Intra-arterial Calcium Channel Blockers |
Clin Neuroradiol. 2022 May 3. doi: 10.1007/s00062-022-01171-0. Online ahead of print.
M Travis Caton Jr 1, Ian T Mark 2, Kazim H Narsinh 2, Amanda Baker 2, Daniel L Cooke 2, Steven W Hetts 2, Christopher F Dowd 2, Van V Halbach 2, Randall T Higashida 2, Nerissa U Ko 3, Sharon A Chung 4, Matthew R Amans 2 |
| 62 | |
Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Toward an Individualized Approach |
Nephron. 2022;146(2):121-137. doi: 10.1159/000520727. Epub 2021 Dec 15.
Javier Villacorta 1, Laura Martinez-Valenzuela 2, Irene Martin-Capon 1, Juliana Bordignon-Draibe 2 |
| 63 | |
Journal Club Review of "Comparison of Two Rituximab Induction Regimens for Antineutrophil Cytoplasm Antibody-Associated Vasculitis: Systematic Review and Meta-Analysis" |
ACR Open Rheumatol. 2022 May;4(5):406-409. doi: 10.1002/acr2.11409. Epub 2022 Feb 4.
|
| 64 | |
Psychometric properties of outcome measurement instruments for ANCA-associated vasculitis: a systematic literature review |
2022 Mar 16;keac175. doi: 10.1093/rheumatology/keac175.Online ahead of print.
Alvise Berti 1, Gonçalo Boleto 2, Peter A Merkel 3, Gunnar Tómasson 4, Sara Monti 5, Kaitlin A Quinn 6, Leslie C Hassett 7, Loreto Carmona 8, Sofia Ramiro 9, OMERACT Vasculitis Working Group |
| 65 | |
Performance of MPO-ANCA and PR3-ANCA immunoassays for the stratification of specific ANCA-associated vasculitis: A systematic review and meta-analysis |
Autoimmun Rev. 2022 Jun;21(6):103100. doi: 10.1016/j.autrev.2022.103100.Epub 2022 Apr 19.
Brandon S Walker 1, Lisa K Peterson 2, Curry Koening 3, Sandra K White 4, Robert L Schmidt 2, Anne E Tebo 5 |
| 66 | |
Systematic Review of Safety and Efficacy of Second- and Third-Generation CD20-Targeting Biologics in Treating Immune-Mediated Disorders |
Front Immunol. 2022 Feb 2;12:788830. doi: 10.3389/fimmu.2021.788830. eCollection 2021. Celine Kaegi 1, Benjamin Wuest 1, Catherine Crowley 1, Onur Boyman 1 2 |
| 67 | |
Alemtuzumab for refractory primary systemic vasculitis-a randomised controlled dose ranging clinical trial of efficacy and safety (ALEVIATE) |
Arthritis Res Ther. 2022 Apr 1;24(1):81.doi: 10.1186/s13075-022-02761-6.
Seerapani Gopaluni 1, Rona Smith 2 3, Donna Goymer 3, Hugh Cahill 3, Elizabeth Broadhurst 3, Elizabeth Wallin 3, Mark McClure 2 3, Afzal Chaudhry 3, David Jayne 2 3 |
| 68 | |
Inflammatory muscle involvement in systemic vasculitis: A systematic review |
Autoimmun Rev. 2022 Mar;21(3):103029. doi: 10.1016/j.autrev.2021.103029.Epub 2021 Dec 29.
Edoardo Conticini 1, Miriana d'Alessandro 2, Suhel Gabriele Al Khayyat 1, Roberto D'Alessandro 1, Emilio D'Ignazio 1, Anna Paola Pata 1, Giulia Vallifuoco 1, Paolo Falsetti 1, Caterina Baldi 1, Marco Bardelli 1, Stefano Gentileschi 1, Claudia Fabiani 3, Maria Antonietta Mazzei 4, Andrea Guarnieri 5, Elena Bargagli 2, Luca Cantarini 6, Bruno Frediani 1 |
| 69 | |
Comparative efficacy and safety of rituximab, mycophenolate, methotrexate, and cyclophosphamide versus azathioprine as maintenance therapy in antineutrophil cytoplasmic antibody-associated vasculitis: A Bayesian network meta-analysis of randomized controlled trials |
Int J Clin Pharmacol Ther. 2022 Feb;60(2):97-105. doi: 10.5414/CP204053.
|
| 70 | |
Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis |
Clin Rheumatol. 2022 Jan;41(1):19-31. doi: 10.1007/s10067-021-05819-z.Epub 2021 Aug 20.
Alberto Floris 1 2, Matteo Piga 3, Elisabetta Chessa 3, Mattia Congia 3, Gian Luca Erre 4, Maria Maddalena Angioni 3, Alessandro Mathieu 3, Alberto Cauli 3 |
| 71 | |
Burden of illness associated with eosinophilic granulomatosis with polyangiitis: a systematic literature review and meta-analysis |
Clin Rheumatol. 2021 Dec;40(12):4829-4836. doi: 10.1007/s10067-021-05783-8.Epub 2021 Jun 23.
Rupert W Jakes 1, Namhee Kwon 2, Beth Nordstrom 3, Rebecca Goulding 3, Kyle Fahrbach 3, Jialu Tarpey 3, Melissa K Van Dyke 4 |
| 72 | |
A systematic review and meta-analysis of the incidence rate of Takayasu arteritis |
Rheumatology (Oxford). 2021 Nov 3;60(11):4982-4990.doi: 10.1093/rheumatology/keab406.
Megan Rutter 1 2, Jonathan Bowley 1, Peter C Lanyon 1 2, Matthew J Grainge 1, Fiona A Pearce 1 2 |
| 73 | |
ANCA Associated Vasculitis Subtypes: Recent Insights and Future Perspectives |
J Inflamm Res. 2022 Apr 21;15:2567-2582. doi: 10.2147/JIR.S284768.eCollection 2022. Keziah Austin # 1, Shalini Janagan # 2, Matthew Wells 3, Helena Crawshaw 4, Stephen McAdoo 5, Joanna C Robson 2 6 |
| 74 | |
Diagnostic and Therapeutic Challenges of Vasculitis |
Can J Cardiol. 2022 Feb 11;S0828-282X(22)00125-8.doi: 10.1016/j.cjca.2022.02.007. Online ahead of print.
|
| 75 | |
Age as a risk factor in vasculitis |
Semin Immunopathol. 2022 Feb 9. doi: 10.1007/s00281-022-00911-1.Online ahead of print.
Andrea D Gloor 1, Gerald J Berry 2, Jorg J Goronzy 1 3, Cornelia M Weyand 4 5 |
| 76 | |
Clinical Features of ANCA-Associated Vasculitis in African American Patients in the United States: A Single-Center Medical Records Review Study |
J Clin Rheumatol. 2022 Mar 21. doi: 10.1097/RHU.0000000000001838. Online ahead of print. Luis Palomino 1, Angelo Gaffo, Dongmei Sun, Sebastian E Sattui |
| 77 | |
Large-vessel vasculitis |
Nat Rev Dis Primers. 2022 Jan 6;7(1):93. doi: 10.1038/s41572-021-00327-5. Dan Pugh 1, Maira Karabayas 2, Neil Basu 3, Maria C Cid 4, Ruchika Goel 5, Carl S Goodyear 3, Peter C Grayson 6, Stephen P McAdoo 7, Justin C Mason 8, Catherine Owen 9, Cornelia M Weyand 10, Taryn Youngstein 8, Neeraj Dhaun 11 |
| 78 | |
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis |
Arthritis Rheumatol. 2022 Mar;74(3):386-392.doi: 10.1002/art.41982.Epub 2022 Feb 2. Peter C Grayson 1, Cristina Ponte 2, Ravi Suppiah 3, Joanna C Robson 4, Anthea Craven 5, Andrew Judge 6, Sara Khalid 5, Andrew Hutchings 7, Raashid A Luqmani 5, Richard A Watts 8, Peter A Merkel 9, DCVAS Study Group DCVAS Study Group: Paul Gatenby, Catherine Hill, Dwarakanathan Ranganathan, Andreas Kronbichler, Daniel Blockmans, Lillian Barra, Simon Carette, Christian Pagnoux, Navjot Dhindsa, Aurore Fifi-Mah, Nader Khalidi, Patrick Liang, Nataliya Milman, Christian Pineau, Xinping Tian, Guochun Wang, Tian Wang, Ming-Hui Zhao, Vladimir Tesar, Bo Baslund, Nevin Hammam, Amira Shahin, Laura Pirila, Jukka Putaala, Bernhard Hellmich, Jörg Henes, Peter Lamprecht, Thomas Neumann, Wolfgang Schmidt, Cord Sunderkoetter, Zoltan Szekanecz, Debashish Danda, Siddharth Das, Rajiva Gupta, Liza Rajasekhar, Aman Sharma, Shrikant Wagh, Michael Clarkson, Eamonn Molloy, Carlo Salvarani, Franco Schiavon, Enrico Tombetti, Augusto Vaglio, Koichi Amano, Yoshihiro Arimura, Hiroaki Dobashi, Shouichi Fujimoto, Masayoshi Harigai, Fumio Hirano, Junichi Hirahashi, Sakae Honma, Tamihiro Kawakami, Shigeto Kobayashi, Hajime Kono, Hirofumi Makino, Kazuo Matsui, Eri Muso, Kazuo Suzuki, Kei Ikeda, Tsutomu Takeuchi, Tatsuo Tsukamoto, Shunya Uchida, Takashi Wada, Hidehiro Yamada, Kunihiro Yamagata, Wako Yumura, Kan Sow Lai, Luis Felipe Flores-Suarez, Andrea Hinojosa, Bram Rutgers, Paul-Peter Tak, Rebecca Grainger, Vicki Quincey, Lisa Stamp, Ravi Suppiah, Emilio Besada, Andreas Diamantopoulos, Jan Sznajd, Elsa Azevedo, Ruth Geraldes, Miguel Rodrigues, Ernestina Santos, Yeong-Wook Song, Sergey Moiseev, Alojzija Hoc?evar, Maria Cinta Cid, Xavier Solanich Moreno, Inoshi Atukorala, Ewa Berglin, Aladdin Mohammed, Mårten Segelmark, Thomas Daikeler, Haner Direskeneli, Gulen Hatemi, Sevil Kamali, Ömer Karadag, Seval Pehlevan, Matthew Adler, Neil Basu, Iain Bruce, Kuntal Chakravarty, Bhaskar Dasgupta, Oliver Flossmann, Nagui Gendi, Alaa Hassan, Rachel Hoyles, David Jayne, Colin Jones, Rainer Klocke, Peter Lanyon, Cathy Laversuch, Raashid Luqmani, Joanna Robson, Malgorzata Magliano, Justin Mason, Win Win Maw, Iain McInnes, John Mclaren, Matthew Morgan, Ann Morgan, Chetan Mukhtyar, Edmond O'Riordan, Sanjeev Patel, Adrian Peall, Joanna Robson, Srinivasan Venkatachalam, Erin Vermaak, Ajit Menon, Richard Watts, Chee-Seng Yee, Daniel Albert, Leonard Calabrese, Sharon Chung, Lindsy Forbess, Angelo Gaffo, Ora Gewurz-Singer, Peter Grayson, Kimberly Liang, Eric Matteson, Peter A Merkel, Jason Springer, Antoine Sreih |
| 79 | |
Cardiovascular disease and ANCA-associated vasculitis: are we missing a beat? |
Clin Kidney J. 2022 Jan 13;15(4):618-623. doi: 10.1093/ckj/sfac009.eCollection 2022 Apr. Lauren Floyd 1, Adam D Morris 1, Alexander Woywodt 1, Ajay Dhaygude 1 |
| 80 | |
Association of COVID-19 antigenicity with the development of antineutrophilic cytoplasmic antibody vasculitis |
Respirol Case Rep. 2021 Dec 27;10(1):e0894. doi: 10.1002/rcr2.894.eCollection 2022 Jan. Jamie R Felzer 1, Delvise T Fogwe 1, Shaher Samrah 2, Clement J Michet Jr 3, Ulrich Specks 4, Misbah Baqir 4, Aahd F Kubbara 4 |
| 81 | |
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Granulomatosis With Polyangiitis |
Arthritis Rheumatol. 2022 Mar;74(3):393-399. doi: 10.1002/art.41986.Epub 2022 Feb 2. Joanna C Robson 1, Peter C Grayson 2, Cristina Ponte 3, Ravi Suppiah 4, Anthea Craven 5, Andrew Judge 6, Sara Khalid 5, Andrew Hutchings 7, Richard A Watts 8, Peter A Merkel 9, Raashid A Luqmani 5, DCVAS Study Group DCVAS Study Group: Paul Gatenby, Catherine Hill, Dwarakanathan Ranganathan, Andreas Kronbichler, Daniel Blockmans, Lillian Barra, Simon Carette, Christian Pagnoux, Navjot Dhindsa, Aurore Fifi-Mah, Nader Khalidi, Patrick Liang, Nataliya Milman, Christian Pineau, Xinping Tian, Guochun Wang, Tian Wang, Ming-Hui Zhao, Vladimir Tesar, Bo Baslund, Nevin Hammam, Amira Shahin, Laura Pirila, Jukka Putaala, Bernhard Hellmich, Jörg Henes, Peter Lamprecht, Thomas Neumann, Wolfgang Schmidt, Cord Sunderkoetter, Zoltan Szekanecz, Debashish Danda, Siddharth Das, Rajiva Gupta, Liza Rajasekhar, Aman Sharma, Shrikant Wagh, Michael Clarkson, Eamonn Molloy, Carlo Salvarani, Franco Schiavon, Enrico Tombetti, Augusto Vaglio, Koichi Amano, Yoshihiro Arimura, Hiroaki Dobashi, Shouichi Fujimoto, Masayoshi Harigai, Fumio Hirano, Junichi Hirahashi, Sakae Honma, Tamihiro Kawakami, Shigeto Kobayashi, Hajime Kono, Hirofumi Makino, Kazuo Matsui, Eri Muso, Kazuo Suzuki, Kei Ikeda, Tsutomu Takeuchi, Tatsuo Tsukamoto, Shunya Uchida, Takashi Wada, Hidehiro Yamada, Kunihiro Yamagata, Wako Yumura, Kan Sow Lai, Luis Felipe Flores-Suarez, Andrea Hinojosa, Bram Rutgers, Paul-Peter Tak, Rebecca Grainger, Vicki Quincey, Lisa Stamp, Ravi Suppiah, Emilio Besada, Andreas Diamantopoulos, Jan Sznajd, Elsa Azevedo, Ruth Geraldes, Miguel Rodrigues, Ernestina Santos, Yeong-Wook Song, Sergey Moiseev, Alojzija Hoc?evar, Maria Cinta Cid, Xavier Solanich Moreno, Inoshi Atukorala, Ewa Berglin, Aladdin Mohammed, Mårten Segelmark, Thomas Daikeler, Haner Direskeneli, Gulen Hatemi, Sevil Kamali, Ömer Karadag, Seval Pehlevan, Matthew Adler, Neil Basu, Iain Bruce, Kuntal Chakravarty, Bhaskar Dasgupta, Oliver Flossmann, Nagui Gendi, Alaa Hassan, Rachel Hoyles, David Jayne, Colin Jones, Rainer Klocke, Peter Lanyon, Cathy Laversuch, Raashid Luqmani, Joanna Robson, Malgorzata Magliano, Justin Mason, Win Win Maw, Iain McInnes, John Mclaren, Matthew Morgan, Ann Morgan, Chetan Mukhtyar, Edmond O'Riordan, Sanjeev Patel, Adrian Peall, Joanna Robson, Srinivasan Venkatachalam, Erin Vermaak, Ajit Menon, Richard Watts, Chee-Seng Yee, Daniel Albert, Leonard Calabrese, Sharon Chung, Lindsy Forbess, Angelo Gaffo, Ora Gewurz-Singer, Peter Grayson, Kimberly Liang, Eric Matteson, Peter A Merkel, Jason Springer, Antoine Sreih |
| 82 | |
Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial |
Ann Rheum Dis. 2022 Mar 9;annrheumdis-2021-221865.doi: 10.1136/annrheumdis-2021-221865. Online ahead of print. Maria C Cid # 1, Sebastian H Unizony # 2, Daniel Blockmans 3, Elisabeth Brouwer 4, Lorenzo Dagna 5 6, Bhaskar Dasgupta 7, Bernhard Hellmich 8, Eamonn Molloy 9, Carlo Salvarani 10 11, Bruce C Trapnell 12, Kenneth J Warrington 13, Ian Wicks 14 15, Manoj Samant 16, Teresa Zhou 16, Lara Pupim 16, John F Paolini 16, KPL-301-C001 Investigators |
| 83 | |
The Clinical Significance of Small Vessel Vasculitis on Temporal Artery Biopsies |
J Neuroophthalmol. 2022 Feb 15. doi: 10.1097/WNO.0000000000001505. Online ahead of print. Julian Quigley 1, Anthony Michael Sammel, Rodger Laurent, Janice Brewer, Edward Hsiao, Geoffrey Schembri, Clare L Fraser |
| 84 | |
Baricitinib for relapsing giant cell arteritis: a prospective open-label 52-week pilot study |
Ann Rheum Dis. 2022 Feb 21;annrheumdis-2021-221961.doi: 10.1136/annrheumdis-2021-221961. Online ahead of print. Matthew J Koster 1, Cynthia S Crowson 2, Rachel E Giblon 2, Jane M Jaquith 3, Ali Duarte-García 3, Eric L Matteson 3, Cornelia M Weyand 3, Kenneth J Warrington 3 |
| 85 | |
Mimickers of Large Vessel Giant Cell Arteritis |
J Clin Med. 2022 Jan 19;11(3):495. doi: 10.3390/jcm11030495. André Ramon 1 2, Hélène Greigert 2 3 4, Paul Ornetti 1 5 6, Bernard Bonnotte 2 3, Maxime Samson 2 3 |
| 86 | |
Addressing the transition to a chronic condition: exploring independent adoption of self-management by patients with ANCA-associated vasculitis |
Rheumatol Adv Pract. 2021 Nov 4;5(3):rkab075. doi: 10.1093/rap/rkab075. eCollection 2021. Ian Litchfield 1, Sheila Greenfield 1, Lorraine Harper 1 2, FAB(V) Trial team |
| 87 | |
Patient reported outcomes in systemic vasculitis |
Curr Opin Rheumatol. 2022 Jan 1;34(1):33-38.doi: 10.1097/BOR.0000000000000850. Helena Crawshaw 1, Matthew Wells 2, Keziah Austin 3, Shalini Janagan 4, Joanna C Robson 4 5 |
| 88 | |
Hypothyroidism in Vasculitis |
Rheumatology (Oxford). 2021 Nov 3;keab817. doi: 10.1093/rheumatology/keab817.Online ahead of print. Tanaz A Kermani 1, David Cuthbertson 2, Simon Carette 3, Nader A Khalidi 4, Curry L Koening 5, Carol A Langford 6, Carol A McAlear 7, Paul A Monach 8, Larry Moreland 9, Christian Pagnoux 3, Philip Seo 10, Ulrich Specks 11, Antoine Sreih 7, Kenneth J Warrington 12, Peter A Merkel 7, Vasculitis Clinical Research Consortium |
| 89 | |
The COVID-19 pandemic and ANCA-associated vasculitis - reports from the EUVAS meeting and EUVAS education forum |
Autoimmun Rev. 2021 Dec;20(12):102986. doi: 10.1016/j.autrev.2021.102986.Epub 2021 Oct 28. Andreas Kronbichler 1, Duvuru Geetha 2, Rona M Smith 3, Allyson C Egan 3, Ingeborg M Bajema 4, Ulf Schönermarck 5, Alfred Mahr 6, Hans-Joachim Anders 5, Annette Bruchfeld 7, Maria C Cid 8, David R W Jayne 3 |
| 90 | |
The effects of plasma exchange in patients with ANCA-associated vasculitis: an updated systematic review and meta-analysis |
BMJ. 2022 Feb 25;376:e064604. doi: 10.1136/bmj-2021-064604. Michael Walsh 1 2 3, David Collister 3 4, Linan Zeng 2 5, Peter A Merkel 6, Charles D Pusey 7, Gordon Guyatt 8 2, Chen Au Peh 9 10, Wladimir Szpirt 11, Toshiko Ito-Hara 12 13, David R W Jayne 14, Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis BMJ Rapid Recommendations Group |
| 91 | |
Updates in ANCA-associated vasculitis |
Eur J Rheumatol. 2022 Feb 14. doi: 10.5152/eujrheum.2022.20248. Online ahead of print. Carolyn Ross 1, Jean-Paul Makhzoum 2, Christian Pagnoux 1 |
| 92 | |
Antigen Specific Humoral and Cellular Immunity Following SARS-CoV-2 Vaccination in ANCA-Associated Vasculitis Patients Receiving B-Cell Depleting Therapy |
Front Immunol. 2022 Jan 28;13:834981. doi: 10.3389/fimmu.2022.834981. eCollection 2022. Paige K Marty 1, Virginia P Van Keulen 1 2, Courtney L Erskine 1 2, Maleeha Shah 1, Amber Hummel 1, Michael Stachowitz 1, Samantha Fatis 1, Dane Granger 3, Matthew S Block 2 4, Alí Duarte-García 5, Kenneth J Warrington 5, Elitza S Theel 3, Xian Zhou 5, Hu Zeng 2 5, Ulrich Specks 1, Patricio Escalante 1, Tobias Peikert 1 2 |
| 94 | |
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis |
Ann Rheum Dis. 2022 Feb 2;annrheumdis-2021-221796.doi: 10.1136/annrheumdis-2021-221796. Online ahead of print. Ravi Suppiah 1, Joanna C Robson 2, Peter C Grayson 3, Cristina Ponte 4, Anthea Craven 5, Sara Khalid 5, Andrew Judge 6 7, Andrew Hutchings 8, Peter A Merkel 9, Raashid A Luqmani 5, Richard A Watts 5 10, DCVAS INVESTIGATORS |
| 95 | |
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis |
Ann Rheum Dis. 2022 Feb 2;annrheumdis-2021-221794.doi: 10.1136/annrheumdis-2021-221794. Online ahead of print. Peter C Grayson 1, Cristina Ponte 2 3, Ravi Suppiah 4, Joanna C Robson 5, Anthea Craven 6, Andrew Judge 6 7, Sara Khalid 6, Andrew Hutchings 8, Raashid A Luqmani 6, Richard A Watts 6 9, Peter A Merkel 10, DCVAS Study Group |
| 96 | |
Management of severe renal disease in anti-neutrophil-cytoplasmic-antibody-associated vasculitis: place of rituximab and plasma exchange? |
Rheumatology (Oxford). 2022 Feb 2;keac046. doi: 10.1093/rheumatology/keac046.Online ahead of print. Pauline Morel 1, Alexandre Karras 2, Raphaël Porcher 3, Xavier Belenfant 4, Vincent Audard 5, Cédric Rafat 6, Guillaume Hanouna 7, Séverine Beaudreuil 8, Cédric Vilain 9, Aurélie Hummel 10, Benjamin Terrier 1, Evangeline Pillebout 11, Matthieu Groh 12, Romain Jouenne 13, Robin Dhote 14, Olivier Fain 15, Matthieu Ponsoye 16, Nicolas Noel 17, Nicolas Limal 18, Xavier Puéchal 1, Claire Le Jeunne 1, Loïc Guillevin 1, Luc Mouthon 1, Alexis Régent 1, French Vasculitis Study Group (FSVG) |
| 97 | |
A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis |
Front Immunol. 2022 Jan 12;12:803175. doi: 10.3389/fimmu.2021.803175. eCollection 2021. Jack Arnold 1, Edward M Vital 1 2, Shouvik Dass 1 2, Aamir Aslam 1 2, Andy C Rawstron 3, Sinisa Savic 1 2, Paul Emery 1 2, Md Yuzaiful Md Yusof 1 2 |
| 98 | |
Incidence and risk factors of venous thromboembolism in ANCA-associated vasculitis: a metaanalysis and metaregression |
Clin Rheumatol. 2021 Jul;40(7):2843-2853.doi: 10.1007/s10067-021-05589-8. Epub 2021 Jan 15. Panupong Hansrivijit 1, Angkawipa Trongtorsak 2, Kinjal P Gadhiya 3, Kriti Lnu 3, Christina T Dimech 3, Charat Thongprayoon 4, Wisit Cheungpasitporn 4, Stewart H Lecker 5 |
| 99 | |
New insights into the epidemiology of ANCA-associated vasculitides in Germany: results from a claims data study |
Rheumatology (Oxford). 2021 Oct 2;60(10):4868-4873.doi: 10.1093/rheumatology/keaa924. Bernhard Hellmich 1, Peter Lamprecht 2, Philip Spearpoint 3, Dieter Götte 3, Angelika Deichmann 4, Ina Buchholz 4, Matthias P Schönermark 4, Peter Rutherford 3 |
| 100 | |
Venous thromboembolism in ANCA-associated vasculitis: a population-based cohort study |
Rheumatology (Oxford). 2021 Oct 2;60(10):4616-4623. doi: 10.1093/rheumatology/keab057. Matina Liapi 1, David Jayne 2, Peter A Merkel 3 4, Mårten Segelmark 5, Aladdin J Mohammad 1 2 |
| 101 | |
Pleuritis and Pericarditis in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis |
Chest. 2021 Aug;160(2):572-581. doi: 10.1016/j.chest.2021.02.049. Epub 2021 Mar 2. Gwen E Thompson 1, Michael H Bourne Jr 2, Marta Casal Moura 3, Misbah Baqir 3, Rodrigo Cartin-Ceba 4, Ashima Makol 5, Matthew J Koster 5, Kenneth J Warrington 5, Bijan J Borah 6, Ulrich Specks 7 |
| 102 | |
What is the meaning of ANCA positivity in IgG4-related disease? |
Oxford). 2021 Aug 2;60(8):3845-3850. doi: 10.1093/rheumatology/keab124. |
| 103 | |
Interstitial Lung Disease in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Patients: Comparison With Idiopathic Pulmonary Fibrosis |
J Clin Rheumatol. 2021 Dec 1;27(8):324-330.doi: 10.1097/RHU.0000000000001357. Minkyung Kwon 1, Augustine S Lee 1, Isabel Mira-Avendano 1, Carlos A Rojas 2, Rolf Grage 2, Andy Abril 3 |
| 104 | |
Comparison of disease activity in patients with ankylosing spondylitis under TNFi or NSAID treatment, is there any difference? An observational study |
Reumatol Clin (Engl Ed). 2021 Apr;17(4):192-196. doi: 10.1016/j.reuma.2019.07.005.Epub 2019 Sep 24.
Mireia Moreno 1, Marta Arévalo 2, Marc Zamora 3, Caridad Pontes 4, Juan Carlos Oliva 5, Jordi Gratacós 1 |
| 105 | |
Pregnancy outcomes in women with primary systemic vasculitis: a retrospective study |
J Matern Fetal Neonatal Med. 2021 Sep;34(17):2771-2777. doi: 10.1080/14767058.2019.1671329.Epub 2019 Oct 1. Vanessa Nguyen 1 2, Danielle Wuebbolt 1 2, Christian Pagnoux 3, Rohan D'Souza 1 |
| 106 | |
Acute ANCA Vasculitis and Asymptomatic COVID-19 |
Pediatrics. 2021 Apr;147(4):e2020033092. doi: 10.1542/peds.2020-033092.Epub 2021 Jan 20. Weston T Powell 1 2 3, Julie A Campbell 4 2 3, Francesca Ross 2, Patricia Peña Jiménez 5 2, Erin R Rudzinski 6, Jane A Dickerson 6 |
| 107 | |
Cyclophosphamide induction dose and outcomes in ANCA-associated vasculitis with renal involvement: A comparative cohort study |
Medicine (Baltimore). 2021 Jul 23;100(29):e26733.doi: 10.1097/MD.0000000000026733. Claudius Speer 1, Christine Altenmüller-Walther 1, Jan Splitthoff 2, Christian Nusshag 1, Florian Kälble 1, Paula Reichel 1, Christian Morath 1, Martin Zeier 1, Raoul Bergner 2, Matthias Schaier 1 |
| 108 | |
Reasons for hospitalization and in-hospital mortality for anti-neutrophil cytoplasmic antibody vasculitides: analysis of the National Inpatient Sample |
Clin Rheumatol. 2021 Aug 28. doi: 10.1007/s10067-021-05880-8. Online ahead of print. Mavi Rivera 1, A Villafranca 2, P Khamooshi 3, V Reyes 3, J Sanchez 3, A Manadan 4 |
| 109 | |
ANCA and anti-glomerular basement membrane double-positive patients: A systematic review of the literature |
Autoimmun Rev. 2021 Jul 7;20(9):102885. doi: 10.1016/j.autrev.2021.102885.Online ahead of print. Rémi Philip 1, Anael Dumont 2, Nicolas Martin Silva 1, Hubert de Boysson 2, Achille Aouba 3, Samuel Deshayes 2 |
| 110 | |
Diagnosing Giant Cell Arteritis: A Comprehensive Practical Guide for the Practicing Rheumatologist |
Rheumatology (Oxford). 2021 Jul 13;keab547. doi: 10.1093/rheumatology/keab547.Online ahead of print. Peter M Andel 1 2, Stavros Chrysidis 3, Julia Geiger 4, Anne Haaversen 5, Glenn Haugeberg 2 6, Geirmund Myklebust 2, Berit D Nielsen 7 8, Andreas Diamantopoulos 5 9 |
| 111 | |
Gastrointestinal involvement in IgA vasculitis: a single-center 11-year study on a cohort of 118 children |
Clin Rheumatol. 2021 Jul 17. doi: 10.1007/s10067-021-05863-9. Online ahead of print. Chiara Rubino 1, Costanza Monacelli 2, Edoardo Marrani 3, Monica Paci 4, Giuseppe Indolfi 1 5, Gabriele Simonini 3 5, Sandra Trapani 6 7 |
| 112 | |
Developing a composite outcome tool to measure response to treatment in ANCA-associated vasculitis: A mixed methods study from OMERACT 2020 |
Semin Arthritis Rheum. 2021 Jul 8;S0049-0172(21)00125-6.doi: 10.1016/j.semarthrit.2021.07.001. Online ahead of print. Kaitlin A Quinn 1, Sara Monti 2, Robin Christensen 3, David Jayne 4, Carol A Langford 5, Georgia E Lanier 6, Alfred Mahr 7, Christian Pagnoux 8, Beverley Shea 9, Peter Tugwell 10, Maria Bjork Viðarsdóttir 11, Gunnar Tomasson 12, Peter A Merkel 13 |
| 113 | |
Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases |
Lancet Rheumatol. 2021 Jul 22. doi: 10.1016/S2665-9913(21)00175-2. Online ahead of print. Jonathan S Hausmann 1 2 3, Kevin Kennedy 4, Julia F Simard 5, Jean W Liew 6, Jeffrey A Sparks 7, Tarin T Moni 8, Carly Harrison 9, Maggie J Larché 10, Mitchell Levine 4 11 12, Sebastian E Sattui 13, Teresa Semalulu 11, Gary Foster 4 11, Salman Surangiwala 14, Lehana Thabane 4, Richard P Beesley 15 16, Karen L Durrant 17, Elsa F Mateus 18, Serena Mingolla 19, Michal Nudel 20, Candace A Palmerlee 21, Dawn P Richards 22, David F L Liew 23, Catherine L Hill 24 25, Suleman Bhana 26, Wendy Costello 27, Rebecca Grainger 28, Pedro M Machado 29 30 31, Philip C Robinson 32, Paul Sufka 33, Zachary S Wallace 34, Jinoos Yazdany 35, Emily Sirotich 4 22, COVID-19 Global Rheumatology Alliance |
| 114 | |
Management of primary vasculitides with biologic and novel small molecule medications |
Curr Opin Rheumatol. 2021 Jan;33(1):8-14. doi: 10.1097/BOR.0000000000000756. |
| 115 | |
Vasculitis as a Major Morbidity Factor in Patients With Partial RAG Deficiency |
Front Immunol. 2020 Oct 21;11:574738. doi: 10.3389/fimmu.2020.574738.eCollection 2020. Christoph B Geier 1, Jocelyn R Farmer 2, Zsofia Foldvari 3, Boglarka Ujhazi 4, Jolanda Steininger 1, John W Sleasman 5, Suhag Parikh 6, Meredith A Dilley 7, Sung-Yun Pai 8 9 10, Lauren Henderson 11, Melissa Hazen 11, Benedicte Neven 12 13 14, Despina Moshous 12 13 15, Svetlana O Sharapova 16, Snezhina Mihailova 17, Petya Yankova 17, Elisaveta Naumova 17, Seza Özen 18, Kevin Byram 19, James Fernandez 19, Hermann M Wolf 1 20, Martha M Eibl 1 21, Luigi D Notarangelo 22, Leonard H Calabrese 19, Jolan E Walter 23 24 |
| 116 | |
The value of anti-neutrophil cytoplasmic antibodies (ANCA) testing for the diagnosis of ANCA-associated vasculitis, a systematic review and meta-analysis |
Autoimmun Rev. 2021 Jan;20(1):102716. doi: 10.1016/j.autrev.2020.102716.Epub 2020 Nov 13. Niels A D Guchelaar 1, Manon M Waling 1, Anviti A Adhin 1, Paul L A van Daele 1, Marco W J Schreurs 2, Saskia M Rombach 3 |
| 117 | |
Incidence and predictors of severe infections in ANCA-associated vasculitis: a population-based cohort study |
Rheumatology (Oxford). 2021 Jun 18;60(6):2745-2754. doi: 10.1093/rheumatology/keaa699. Jens Rathmann 1, David Jayne 2, Mårten Segelmark 3, Göran Jönsson 4, Aladdin J Mohammad 1 2 |
| 118 | |
Defining a Therapeutic Window for Rituximab Maintenance Therapy in ANCA-Associated Vasculitis: A Longitudinal Observational Study |
J Clin Rheumatol. 2020 Dec 15;Publish Ahead of Print:10.1097/RHU.0000000000001688. doi: 10.1097/RHU.0000000000001688. Online ahead of print. |
| 119 | |
Granulomatosis with polyangiitis: Study of 795 patients from the French Vasculitis Study Group registry |
Semin Arthritis Rheum. 2021 Apr;51(2):339-346. doi: 10.1016/j.semarthrit.2021.02.002.Epub 2021 Feb 10. Michele Iudici 1, Christian Pagnoux 2, Delphine S Courvoisier 3, Pascal Cohen 4, Mohamed Hamidou 5, Achille Aouba 6, François Lifermann 7, Marc Ruivard 8, Olivier Aumaître 8, Bernard Bonnotte 9, François Maurier 10, Olivier Decaux 11, Eric Hachulla 12, Alexandre Karras 13, Chahéra Khouatra 14, Noémie Jourde-Chiche 15, Jean-François Viallard 16, Claire Blanchard-Delaunay 17, Pascal Godmer 18, Alain Le Quellec 19, Thomas Quéméneur 20, Claire de Moreuil 21, Alexis Régent 4, Benjamin Terrier 4, Luc Mouthon 4, Loïc Guillevin 4, Xavier Puéchal 22, French Vasculitis Study Group |
| 120 | |
Pulmonary Low Attenuation Areas on CT in ANCA-associated Vasculitis: A quantitative and semi-quantitative analysis correlated with pulmonary function testing for obstructive airway disease |
Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(4):e2020016. doi: 10.36141/svdld.v37i4.9584.Epub 2020 Dec 16. Christian W Cox 1, Brian J Bartholmai 1, Misbah Baqir 1, Jennifer R Geske 1, Ulrich Specks 1 |
| 123 | |
Impact of Cardiovascular Risk Factors on the Occurrence of Cardiovascular Events in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitides |
J Clin Med. 2021 May 25;10(11):2299. doi: 10.3390/jcm10112299. Camille Roubille 1 2, Soledad Henriquez 3 4, Cédric Mercuzot 1, Claire Duflos 5, Bertrand Dunogue 3 4, Karine Briot 4 6, Loic Guillevin 3 4, Benjamin Terrier 3 4, Pierre Fesler 1 2 |
| 124 | |
Interstitial Lung Disease Worsens Short- and Long-Term Outcomes of Systemic Rheumatic Disease Patients Admitted to the ICU: A Multicenter Study |
J Clin Med. 2021 Mar 3;10(5):1037. doi: 10.3390/jcm10051037. Lorrain Banuls 1, Juliette Vanoverschelde 2, Fanny Garnier 1, Matthieu Amalric 1, Samir Jaber 3 4, Jonathan Charbit 5, Kevin Chalard 6, Marc Mourad 4 7, Nacim Benchabane 1 4, Racim Benomar 1, Noemie Besnard 1, Delphine Daubin 1, Vincent Brunot 1, Kada Klouche 1 4, Romaric Larcher 1 4 |
| 125 | |
Renal Arteries Revisited: Anatomy, Pathologic Entities, and Implications for Endovascular Management |
Radiographics. May-Jun 2021;41(3):909-928. doi: 10.1148/rg.2021200162. Richard D White 1, Katherine S Moore 1, M Ghali Salahia 1, W Rhodri Thomas 1, Andrew C Gordon 1, Ian M Williams 1, Andrew M Wood 1, Ian A Zealley 1 |
| 126 | |
Antineutrophil Cytoplasmic Antibody-associated Vasculitis Management 2020: Where Are We Now? |
J Rheumatol. 2021 Mar 1;jrheum.201351. doi: 10.3899/jrheum.201351.Online ahead of print. |
| 127 | |
Glucocorticoid maintenance therapy and severe infectious complications in ANCA-associated vasculitis: a retrospective analysis |
Rheumatol Int. 2021 Feb;41(2):431-438. doi: 10.1007/s00296-020-04752-9. Epub 2020 Nov 22. Claudius Speer 1, Christine Altenmüller-Walther 2, Jan Splitthoff 3, Christian Nusshag 2, Florian Kälble 2, Paula Reichel 2, Christian Morath 2, Martin Zeier 2, Raoul Bergner 3, Matthias Schaier 2 |
| 128 | |
Rituximab, Cyclophosphamide, and Corticosteroids for ANCA Vasculitis: The Good, the Bad, and the Ugly |
Kidney Blood Press Res. 2020;45(6):784-791. doi: 10.1159/000509608.Epub 2020 Oct 12. |
| 129 | |
The role of plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis |
Clin Rheumatol. 2021 Apr;40(4):1447-1456. doi: 10.1007/s10067-020-05390-z.Epub 2020 Sep 15. Ioannis Bellos 1, Ioannis Michelakis 2, Dionysis Nikolopoulos 3 4 |
| 130 | |
Small vessel vasculitis secondary to Mycobacterium chelonae |
Rheumatol Int. 2020 Sep 5. doi: 10.1007/s00296-020-04697-z.Online ahead of print. Monica Weinberg 1, Ayse Bag-Ozbek 2 3, Davina Chen 1, Qingping Yao 1 |
| 131 | |
Neutrophil Extracellular Traps: A Potential Therapeutic Target in MPO-ANCA Associated Vasculitis? |
Front Immunol. 2021 Mar 15;12:635188. doi: 10.3389/fimmu.2021.635188.eCollection 2021. |
| 132 | |
Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study |
Rheumatol Int. 2021 Apr 3;1-10. doi: 10.1007/s00296-021-04847-x. Online ahead of print. |
| 133 | |
Pregnancy Outcomes in Systemic Vasculitides |
Curr Rheumatol Rep. 2020 Aug 26;22(10):63. doi: 10.1007/s11926-020-00940-5. |
| 134 | |
Randomized clinical trials in ANCA-associated vasculitis: a systematic analysis of the WHO - International Clinical Trials Registry Platform |
Orphanet J Rare Dis. 2020 May 29;15(1):130. doi: 10.1186/s13023-020-01408-6. Michele Iudici 1, Xavier Puéchal 2, Alejandro Brigante 3, Ignacio Atal 4, Cem Gabay 5 |
| 135 | |
Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes |
Rheumatology (Oxford). 2021 Feb 1;60(2):617-628. doi: 10.1093/rheumatology/keaa215. Sara Monti 1 2, Anthea Craven 3, Catherine Klersy 4, Carlomaurizio Montecucco 1, Roberto Caporali 1, Richard Watts 5, Peter A Merkel 6, Raashid Luqmani 3, DCVAS Collaborators
|
| 136 | |
ANCA autoantigen gene expression highlights neutrophil heterogeneity where expression in normal-density neutrophils correlates with ANCA-induced activation |
Kidney Int. 2020 Sep;98(3):744-757. doi: 10.1016/j.kint.2020.04.037. Epub 2020 May 21. Britta E Jones 1, Carolina A Herrera 1, Christian Agosto-Burgos 1, Joshua Starmer 2, William A Bass 1, Caroline J Poulton 1, Lauren Blazek 1, Candace D Henderson 1, Yichun Hu 1, Susan L Hogan 1, Peiqi Hu 3, Hong Xiao 3, Eveline Y Wu 4, Dhruti P Chen 1, J Charles Jennette 5, Meghan E Free 1, Ronald J Falk 6, Dominic J Ciavatta 7 |
| 137 | |
Pathogenesis of ANCA-associated vasculitis: an emerging role for immunometabolism |
Rheumatology (Oxford). 2020 May 1;59(Suppl 3):iii33-iii41.doi: 10.1093/rheumatology/keaa023. |
| 138 | |
Reducing the initial number of rituximab maintenance-therapy infusions for ANCA-associated vasculitides: randomized-trial post-hoc analysis |
Rheumatology (Oxford). 2020 Oct 1;59(10):2970-2975.doi: 10.1093/rheumatology/kez621. Pierre Charles 1 2, Agnès Dechartres 3, Benjamin Terrier 1, Pascal Cohen 1, Stanislas Faguer 4, Antoine Huart 4, Mohamed Hamidou 5, Christian Agard 5, Bernard Bonnotte 6, Maxime Samson 6, Alexandre Karras 7, Noémie Jourde-Chiche 8, François Lifermann 9, Pierre Gobert 10, Catherine Hanrotel-Saliou 11, Pascal Godmer 12, Nicolas Martin-Silva 13, Grégory Pugnet 14, Marie Matignon 15, Olivier Aumaitre 16, Jean-François Viallard 17, François Maurier 18, Nadine Meaux-Ruault 19, Sophie Rivière 20, Jean Sibilia 21, Xavier Puéchal 1, Luc Mouthon 1, Loïc Guillevin 1, French Vasculitis Study Group |
| 139 | |
Association of Cigarette Smoking With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis |
JAMA Intern Med. 2020 Jun 1;180(6):870-876.doi: 10.1001/jamainternmed.2020.0675. Greg McDermott 1, Xiaoqing Fu 2 3, John H Stone 1 4, Rachel Wallwork 1 4, Yuqing Zhang 1 2 4 3, Hyon K Choi 1 2 4 3, Zachary S Wallace 1 2 4 3 |
| 142 | |
Management of ANCA associated vasculitis |
BMJ. 2020 Mar 18;368:m421. doi: 10.1136/bmj.m421. |
| 143 | |
Complications of therapy for ANCA-associated vasculitis |
Rheumatology (Oxford). 2020 May 1;59(Suppl 3):iii74-iii78. doi: 10.1093/rheumatology/kez618. |
| 144 | |
Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide? |
Front Immunol. 2019 Dec 6;10:2855. doi: 10.3389/fimmu.2019.02855.eCollection 2019. Zachary S Wallace 1 2 3 4, John H Stone 2 3 4 |
| 145 | |
All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type |
Rheumatology (Oxford). 2020 Sep 1;59(9):2308-2315. doi: 10.1093/rheumatology/kez589. Zachary S Wallace 1 2 3 4, Xiaoqing Fu 1 2 3, Tyler Harkness 1 2 3, John H Stone 2 3 4, Yuqing Zhang 1 2 3 4, Hyon Choi 2 3 4 |
| 147 | |
Long-term outcomes in elderly patients with ANCA-associated vasculitis |
Rheumatology (Oxford). 2020 May 1;59(5):1076-1083. doi: 10.1093/rheumatology/kez388. Dominic McGovern 1, Sam P Williams 1, Katrina Parsons 2, Tariq E Farrah 1 3, Peter J Gallacher 1 3, Eve Miller-Hodges 1 3, David C Kluth 1, Robert W Hunter 1 3, Neeraj Dhaun 1 3 |
| 148 | |
Therapeutic options for patients with rare rheumatic diseases: a systematic review and meta-analysis |
Orphanet J Rare Dis. 2020 Oct 31;15(1):308. doi: 10.1186/s13023-020-01576-5. Tim T A Bender 1, Judith Leyens 2, Julia Sellin 1, Dmitrij Kravchenko 3, Rupert Conrad 4, Martin Mücke 5, Matthias F Seidel 6 |
| 149 | |
Complementary Use of U.S. FDA's Adverse Event Reporting System and Sentinel System to Characterize Direct Oral Anticoagulants-Associated Cutaneous Small Vessel Vasculitis |
Pharmacotherapy. 2020 Nov;40(11):1099-1107. doi: 10.1002/phar.2468. Epub 2020 Nov 8. Mohamed Mohamoud 1, Casie Horgan 2, Efe Eworuke 3, Elizabeth Dee 2, Justin Bohn 2, Oren Shapira 2, Monica A Munoz 1, Danijela Stojanovic 4, Veronica Sansing-Foster 5, Adebola Ajao 3, Lois La Grenade 1 |
| 150 | |
Low Utility of Radiological Imaging in Evaluating Cutaneous Small-Vessel Vasculitis: A Multi-institutional Retrospective Study |
J Am Acad Dermatol. 2020 Oct 1;S0190-9622(20)32644-X. doi: 10.1016/j.jaad.2020.09.051.Online ahead of print. Andrew C Walls 1, Ryan S Din 1, Jean-Phillip Okhovat 2, Peter B Chansky 3, Robert G Micheletti 3, Arash Mostaghimi 1 |
| 151 | |
An update on the microbiome in vasculitis |
Curr Opin Rheumatol. 2021 Jan;33(1):15-23. doi: 10.1097/BOR.0000000000000758. Shahna Tariq 1, Alison H Clifford |
| 152 | |
Systemic Lupus Erythematosus-associated Retinal Vasculitis Treated with Adalimumab |
Ocul Immunol Inflamm. 2020 Nov 16;1-5. doi: 10.1080/09273948.2020.1828937.Online ahead of print. Sanjana Kuthyar 1, Alexander C Barnes 1, Javeria Bhawal 2, Joseph Christiansen 1, Jessica G Shantha 1, Steven Yeh 1 |
| 153 | |
Environmental risk factors associated with ANCA associated vasculitis: A systematic mapping review |
Autoimmun Rev. 2020 Nov;19(11):102660. doi: 10.1016/j.autrev.2020.102660. Epub 2020 Sep 15. Jennifer Scott 1, Jack Hartnett 1, David Mockler 2, Mark A Little 3 |
| 154 | |
Morbidity and Mortality of Large-Vessel Vasculitides |
Curr Rheumatol Rep. 2020 Oct 16;22(12):86. doi: 10.1007/s11926-020-00963-y. Matthew J Koster 1, Kenneth J Warrington 2, Eric L Matteson 2 |
| 155 | |
Vasculitis patient journey: a scoping review of patient experiences with vasculitis |
Clin Rheumatol. 2020 Sep 30. doi: 10.1007/s10067-020-05398-5.Online ahead of print. Navjeet Gill 1, Jan Willem Cohen Tervaert 2, Elaine Yacyshyn 3 |
| 156 | |
Adjunctive Treatment With Avacopan, an Oral C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis |
ACR Open Rheumatol. 2020 Nov;2(11):662-671. doi: 10.1002/acr2.11185. Epub 2020 Oct 31. Peter A Merkel 1, John Niles 2, Richard Jimenez 3, Robert F Spiera 4, Brad H Rovin 5, Andrew Bomback 6, Christian Pagnoux 7, Antonia Potarca 8, Thomas J Schall 8, Pirow Bekker 8, CLASSIC Investigators Collaborators
Louis-Philippe Girard, Yih Chang Chen Lin, Galina Marder, Jennifer Murphy, William Shergy, Christopher Charles Striebich, Areena Swarup, James Tumlin |
| 157 | |
CanVasc consensus recommendations for the management of antineutrophil cytoplasm antibody-associated vasculitis: 2020 update |
J Rheumatol. 2020 Sep 15;jrheum.200721. doi: 10.3899/jrheum.200721. Online ahead of print. Arielle Mendel 1, Daniel Ennis 1, Ellen Go 1, Volodko Bakowsky 1, Corisande Baldwin 1, Susanne M Benseler 1, David A Cabral 1, Simon Carette 1, Marie Clements-Baker 1, Alison Clifford 1, Jan Willem Cohen Tervaert 1, Gerard Cox 1, Natasha Dehghan 1, Christine Dipchand 1, Navjot Dhindsa 1, Leilani Famorca 1, Aurore Fifi-Mah 1, Stephanie Garner 1, Louis-Philippe Girard 1, Clode Lessard 1, Patrick Liang 1, Damien Noone 1, Jean-Paul Makhzoum 1, Nataliya Milman 1, Christian A Pineau 1, Heather N Reich 1, Maxime Rhéaume 1, David B Robinson 1, Dax G Rumsey 1, Tanveer E Towheed 1, Judith Trudeau 1, Marinka Twilt 1, Elaine Yacyshyn 1, Rae Yeung 1, Lillian Barra 1, Nader Khalidi 1, Christian Pagnoux 1 |
| 158 | |
Use and reporting of outcome measures in randomized trials for anti-neutrophil cytoplasmic antibody-associated vasculitis: a systematic literature review of randomized trials |
Semin Arthritis Rheum. 2020 Sep 29;50(6):1314-1325.doi: 10.1016/j.semarthrit.2020.09.010. Online ahead of print. Sara Monti 1, Kaitlin A Quinn 2, Robin Christensen 3, David Jayne 4, Carol Langford 5, Georgia E Lanier 6, Alfred Mahr 7, Christian Pagnoux 8, Maria Bjork Viðarsdóttir 9, Peter A Merkel 10, Gunnar Tomasson 11 |
| 159 | |
Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis |
Front Immunol. 2020 Sep 3;11:2053. doi: 10.3389/fimmu.2020.02053. eCollection 2020. Gwen E Thompson 1 2, Lynn A Fussner 3, Amber M Hummel 2, Darrell R Schroeder 2, Francisco Silva 4, Melissa R Snyder 2, Carol A Langford 5, Peter A Merkel 6 7, Paul A Monach 8, Philip Seo 9, Robert F Spiera 10, E William St Clair 11, John H Stone 12, Ulrich Specks 2 |
| 160 | |
ANCA-associated vasculitis |
Nat Rev Dis Primers. 2020 Aug 27;6(1):71. doi: 10.1038/s41572-020-0204-y. A Richard Kitching 1 2, Hans-Joachim Anders 3, Neil Basu 4, Elisabeth Brouwer 5, Jennifer Gordon 6, David R Jayne 7, Joyce Kullman 8, Paul A Lyons 7 9, Peter A Merkel 10, Caroline O S Savage 11, Ulrich Specks 12, Renate Kain 13 |
| 161 | |
ANCA-associated vasculitides: Recommendations of the French Vasculitis Study Group on the use of immunosuppressants and biotherapies for remission induction and maintenance |
Presse Med. 2020 Jul 6;49(3):104031. doi: 10.1016/j.lpm.2020.104031. Online ahead of print. Benjamin Terrier 1, Pierre Charles 2, Olivier Aumaître 3, Alexandre Belot 4, Bernard Bonnotte 5, Yoann Crabol 6, Cécile-Audrey Durel 7, Mikael Ebbo 8, Noémie Jourde-Chiche 9, Jean-Christophe Lega 10, Xavier Puéchal 11, Grégory Pugnet 12, Thomas Quemeneur 13, Camillo Ribi 14, Maxime Samson 4, Frédéric Vandergheynst 15, Loïc Guillevin 11, French Vasculitis Study Group |
| 162 | |
2020 international consensus on ANCA testing beyond systemic vasculitis |
Autoimmun Rev. 2020 Sep;19(9):102618. doi: 10.1016/j.autrev.2020.102618.Epub 2020 Jul 12. Sergey Moiseev 1, Jan Willem Cohen Tervaert 2, Yoshihiro Arimura 3, Dimitrios P Bogdanos 4, Elena Csernok 5, Jan Damoiseaux 6, Marc Ferrante 7, Luis Felipe Flores-Suárez 8, Marvin J Fritzler 9, Pietro Invernizzi 10, David Jayne 11, J Charles Jennette 12, Mark A Little 13, Stephen P McAdoo 14, Pavel Novikov 15, Charles D Pusey 14, Antonella Radice 16, Alan D Salama 17, Judith A Savige 18, Mårten Segelmark 19, Yehuda Shoenfeld 20, Renato A Sinico 21, Maria-José Sousa 22, Ulrich Specks 23, Benjamin Terrier 24, Athanasios G Tzioufas 25, Severine Vermeire 7, Ming-Hui Zhao 26, Xavier Bossuyt 27 |
| 163 | |
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis |
Ann Rheum Dis. 2020 Jun 24;annrheumdis-2019-216863.doi: 10.1136/annrheumdis-2019-216863. Online ahead of print. Rona M Smith 1 2, Rachel Bronwen Jones 2, Ulrich Specks 3, Simon Bond 4, Marianna Nodale 4, Reem Aljayyousi 5, Jacqueline Andrews 6, Annette Bruchfeld 7, Brian Camilleri 8, Simon Carette 9, Chee Kay Cheung 10, Vimal Derebail 11, Tim Doulton 12, Lindsy Forbess 13, Shouichi Fujimoto 14, Shunsuke Furuta 15, Ora Gewurz-Singer 16, Lorraine Harper 17, Toshiko Ito-Ihara 18, Nader Khalidi 19, Rainer Klocke 20, Curry Koening 21, Yoshinori Komagata 22, Carol Langford 23, Peter Lanyon 24, Raashid Ahmed Luqmani 25, Hirofumi Makino 26, Carole McAlear 27, Paul Monach 28, Larry W Moreland 29, Kim Mynard 2, Patrick Nachman 11, Christian Pagnoux 30, Fiona Pearce 31, Chen Au Peh 32, Charles Pusey 33, Dwarakanathan Ranganathan 34, Rennie L Rhee 35, Robert Spiera 36, Antoine G Sreih 37, Vladimir Tesar 38, Giles Walters 39, Michael H Weisman 13, Caroline Wroe 40, Peter Merkel 41, David Jayne 42 2, RITAZAREM coinvestigators; RITAZAREM co-investigators
Collaborators Y Arimura, M Clarkson, J de Zoysa, T Endo, Y Hamano, H Kono, S Lawman, E Muso, K Sada, R Smith, K Suzuki, T Tsukamoto, S Uchida, A Vaglio, R Watts |
| 164 | |
Epidemiology, Time-trends and Outcomes of Serious Infections in Patients With Vasculitis: A 19-year National Study |
Arthritis Care Res (Hoboken). 2020 Jun 11.doi: 10.1002/acr.24348. Online ahead of print. Jasvinder A Singh 1 2 3, John D Cleveland 2 |
| 165 | |
Utility of the Brief Illness Perception Questionnaire to Monitor Patient Beliefs in Systemic Vasculitis |
Rheumatol. 2020 Apr 1;jrheum.190828. doi: 10.3899/jrheum.190828. Online ahead of print. Mollie N Schwartz 1, Casey A Rimland 1, Kaitlin A Quinn 1, Marcela Ferrada 1, K Bates Gribbons 1, Joel S Rosenblum 1, Wendy Goodspeed 1, Elaine Novakovich 1, Peter C Grayson 1 |
| 166 | |
Treatment Outcomes of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Patients Over Age 75 Years: A Meta-Analysis |
Morris AD1, Elsayed ME2, Ponnusamy A2, Rowbottom A3, Martin F4, Geetha D5, Dhaygude AP2. Am J Nephrol. 2020 Mar 11:1-9. doi: 10.1159/000506532. [Epub ahead of print] |
| 167 | |
Complications of therapy for ANCA-associated vasculitis |
Smith R1,2. Rheumatology (Oxford). 2020 Jan 20. pii: kez618. doi: 10.1093/rheumatology/kez618. [Epub ahead of print] |
| 168 | |
All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type |
Wallace ZS1,2,3,4, Fu X1,2,3, Harkness T1,2,3, Stone JH2,3,4, Zhang Y1,2,3,4, Choi H2,3,4. Rheumatology (Oxford). 2019 Dec 17. pii: kez589. doi: 10.1093/rheumatology/kez589. [Epub ahead of print] |
| 169 | |
Long-term outcomes in elderly patients with ANCA-associated vasculitis |
McGovern D1, Williams SP1, Parsons K2, Farrah TE1,3, Gallacher PJ1,3, Miller-Hodges E1,3, Kluth DC1, Hunter RW1,3, Dhaun N1,3. Rheumatology (Oxford). 2019 Sep 17. pii: kez388. doi: 10.1093/rheumatology/kez388. [Epub ahead of print] |
| 170 | |
Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide? |
Wallace ZS1,2,3,4, Stone JH2,3,4. Front Immunol. 2019 Dec 6;10:2855. doi: 10.3389/fimmu.2019.02855. eCollection 2019. |
| 171 | |
Anti-neutrophil Cytoplasmic Antibodies (ANCA) as Disease Activity Biomarkers in a "Personalized Medicine Approach" in ANCA-Associated Vasculitis |
Osman MS1, Tervaert JWC2. Curr Rheumatol Rep. 2019 Dec 26;21(12):76. doi: 10.1007/s11926-019-0872-3. |
| 172 | |
Remission maintenance in ANCA-associated vasculitis: does one size fit all? |
Berti A1,2, Specks U2. Expert Rev Clin Immunol. 2019 Dec;15(12):1273-1286. doi: 10.1080/1744666X.2020.1693260. Epub 2019 Nov 24. |